Our Profile

Cytopeutics is one of the leading and responsible pioneers in stem cell research and treatment. After more than a decade of evidence-based research and development, combining the expertise of scientists around the world, Cytopeutics is now ready to offer its capabilities to help people with diseases that were previously deemed incurable.

At Cytopeutics, our goal is to bring comprehensive stem cell treatment solutions to Malaysia and Asia Pacific and hopefully to global region so that lives can be improved for the better.  We currently have concluded our research in heart failures, heart attack, refractory angina, peripheral artery disease, osteoarthritis, and diabetic foot ulcer, and we will progressively offer clinically-tested treatments under observation.

Our pilot programmes are conducted with utmost professionalism.  Presently our treatment uses only the patients’ own stem cell (autologous treatment) from their own bone marrow. Under our patented technology and protocol, the cells are handled under the strictest standards, in a certified clean room environment and transplanted to patient only by highly qualified professionals.

 

Our Vision

To be the global leader in stem cell treatment.

 

Our Mission 

To provide proven stem cell therapies in a professional, responsible and ethical manner for the benefit of people everywhere.

 

Board of Advisors

Prof Dr Cheong Soon Keng
Medical and Technical Advisor

MBBS (Malaya), MRCP (UK), DCP (London),  FRCP (Glasg), FRCP (Edin), FRCPA (Australia), FAMM (Malaysia), FASc (Malaysia)

Experience:

•          Senior Consultant Haematologist, International Medical University, Malaysia

•          Emeritus Professor, National University of Malaysia

•          Head of Research Unit MAKNA-HUKM Collaboration , Malaysia

•          President, College of Pathology, Academy of Medicine, Malaysia

 

Adj Prof Dr Lian QiZhou
Technical Advisor

MBBS (Fujian), MMED Fujian China, MD Harbin China

 

 

 

Experience:

•          Principle Investigator in Stem Cell Research in Queen Mary Hospital of Hong Kong, Hong Kong

•          Principle Investigator in Stem Cell Research in National University of Singapore, Singapore

•          Research Fellow in Genome Institute of Singapore, Singapore

•          Research Fellow in Utrecht University Medical Centre, Netherlands

 

Assoc Prof Dr Chin Sze Piaw
Clinical and Research Advisor

MBBS (Newcastle, UK), MRCP (UK), FNHAM-elect (Mal)

 

 

 

 

Experience:

•          Consultant Cardiologist, Mawar Renal Medical Centre

•          Associate Professor, International Medical University, Malaysia

•          Secretary, National Cardiovascular Diseases, Malaysia

•          Research Fellow, Haemostasis , Vascular & Cell Biology Unit, UK 

 

Facilities

Patient’s bone marrow cells will be processed, isolated, and cultured in our Class 100 Clean Room, which is an internationally-certified cell culture facility. It follows the guidelines for Good Manufacturing Practice (GMP) and internally audited on a regular basis. Strict SOPs are in place to ensure that our cell products are of a consistently high-quality and standard for clinical research applications.

Why Cytopeutics. . .

• First to isolate and culture Mesenchymal Stem Cells (MSC) in Malaysia.

• First to to produce MSC on a clinical commercial scale using proprietary, animal-free medium in Malaysia.

• First to offer MSC pilot treatments in Malaysia.

• Dedicated and renowned stem cell experts from reputable local and international institutions and       hospitals.

  

  We provide complete Needle-to-Needle^TM service.

• Expertise with more than 15 years of experience in stem cell research and development.

• Highly successful pilot treatment results.

• Needle-to-Needle™ service.

• Comprehensive support to doctors.

• Full patient information and consent.

• Complete follow up program.

Back to Top